Pharmaids Pharmaceuticals Limited (BOM:524572)
42.46
-1.79 (-4.05%)
At close: Jan 23, 2026
Pharmaids Pharmaceuticals Market Cap
Pharmaids Pharmaceuticals has a market cap or net worth of 1.5 billion as of January 23, 2026. Its market cap has decreased by -44.84% in one year.
Market Cap
1.50B
Enterprise Value
1.69B
Revenue
248.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.46
Market Cap Chart
Since January 11, 2002, Pharmaids Pharmaceuticals's market cap has increased from 12.26M to 1.50B, an increase of 12,114.48%. That is a compound annual growth rate of 22.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 1.56B | -7.15% |
| Dec 31, 2025 | 1.68B | -32.38% |
| Dec 31, 2024 | 2.49B | 137.65% |
| Dec 29, 2023 | 1.05B | 185.46% |
| Dec 26, 2022 | 366.41M | 131.65% |
| Dec 31, 2021 | 158.17M | -6.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxygenta Pharmaceutical | 2.15B |
| Ambalal Sarabhai Enterprises | 2.00B |
| Aayush Wellness | 1.81B |
| Astonea Labs | 1.68B |
| Bilcare | 1.60B |
| Quest Laboratories | 1.58B |
| Coral Laboratories | 1.57B |
| Parnax Lab | 1.42B |